Patent application number | Description | Published |
20080260968 | METHOD OF FORMING AMORPHOUS CARBON LAYER USING CROSS TYPE HYDROCARBON COMPOUND AND METHOD OF FORMING LOW-K DIELECTRIC LAYER USING THE SAME - A method of forming an amorphous carbon layer using a cross type hydrocarbon compound as a precursor and a method of forming a low-k dielectric layer using the same are disclosed. The present invention includes a step (a) of vaporizing a precursor containing a cross type hydrocarbon compound, a step (b) of supplying the vaporized precursor and a additive gas into a reaction chamber via a shower head, wherein the precursor and the additive gas are changed into plasma state, and a step (c) of depositing the amorphous carbon layer for the hard mask or the low-k dielectric in the reaction chamber. | 10-23-2008 |
20100048869 | AGENT COMPRISING G-CSF FOR PREVENTION AND TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY - Disclosed is an agent for preventing and treating diabetic peripheral neuropathy including a granulocyte colony stimulating factor (G-CSF) as an active ingredient, which is able to improve nerve conduction velocity and pain sensitivity by regenerating blood vessels in peripheral tissues and rehabilitating damaged nerve tissues. | 02-25-2010 |
20100240967 | BELT WITH HEALTH MANAGEMENT FUNCTION - A belt with a health management function includes a health information extraction module extracting health related information from various biomedical signals, a buckle housing the health information extraction module, and a strap connected to an end of the buckle. The health information extraction module includes a sensor module detecting various biomedical signals, and a process/extraction unit digitally processing the detected biomedical signals and extracting the health related information from the processed digital signals. | 09-23-2010 |
20110020268 | AGENT COMPRISING G-CSF FOR TREATMENT OF TRAUMATIC PERIPHERAL NERVE INJURY AND METHOD FOR TREATING TRAUMATIC PERIPHERAL NERVE INJURY WITH THE SAME - Disclosed herein are an agent for treating traumatic peripheral nerve injury comprising a granulocyte colony stimulating factor (G-CSF) as an active ingredient and a method for treating traumatic peripheral nerve injury with the same. | 01-27-2011 |
20110076247 | AGENT COMPRISING G-CSF FOR PREVENTION AND TREATMENT OF DIABETIC PERIPHERAL NEUROPATHY - Disclosed is an agent for preventing and treating diabetic peripheral neuropathy including a granulocyte colony stimulating factor (G-CSF) as an active ingredient, which is able to improve nerve conduction velocity and pain sensitivity by regenerating blood vessels in peripheral tissues and rehabilitating damaged nerve tissues. | 03-31-2011 |
20120186927 | Power Supply Device, Power Acquisition Device and Safety System for Electromagnetic Induction-Powered Electric Vehicle - It is provided a power supply device and a power acquisition device for an electromagnetic induction-powered electric vehicle that increase a power transfer efficiency by maximizing a lateral deviation tolerance and by minimizing a gap between the power acquisition device and the power supply device while preventing the power acquisition device from colliding with an obstacle present on a road and being damaged by the collision. | 07-26-2012 |
20120258830 | GEARBOX HAVING MULTIPLE INPUT AXLES AND TRANSMISSION DEVICE USING THE SAME - A transmission device for application to a vehicle is disclosed. The transmission device includes a planetary gear including means for restricting degrees of freedom and a gearbox having two input axles. The root axle of the gearbox is functionally connected to the planetary shaft of carrier or to the planetary shaft of the ring gear. An end portion of the first axle of the gearbox is functionally connected to the root axle via a synchronizing device and the other end portion to the driving axle of the vehicle or to the internal combustion engine. An end portion of the second axle is a free end and the other end portion is connected to the root axle. The second axle has a direction of rotation opposite to that of the root axle and the third axle a direction of rotation opposite to that of the connected planetary shaft. | 10-11-2012 |
20130180650 | SINGLE-WALLED CARBON NANOTUBE SATURABLE ABSORBER PRODUCTION VIA MULTI-VACUUM FILTRATION METHOD - Provided is single-walled carbon nanotube saturable absorber production via a multi-vacuum filtration method, and more particularly, single-walled carbon nanotube saturable absorber production via a multi-vacuum filtration method, capable of depositing a carbon nanotube thin film on a filter using a vacuum chamber and a membrane filter, etching the filter using an etchant so as to be transferred to an upper surface of the polymer, coating the polymer on the carbon nanotube to thereby produce a carbon nanotube saturable absorber, as a method of producing a carbon nanotube thin film to transfer the thin film to the polymer using a multi-filtration method in order to produce a passive saturable absorber to be used in laser oscillation. | 07-18-2013 |
20130182726 | PRODUCES VARIOUS TYPES OF PULSES BY CONTROLLING THE DISTANCE BETWEEN THE SATURABLE ABSORBER CONNECTORS - Provided is a device of generating various types of pulses by controlling a distance between saturable absorber connectors, and more particularly, a device of generating various types of pulses by controlling a distance between saturable absorber connectors, capable of actively controlling a distance between saturable absorbers to completely overcome a disadvantage that an opened space is present in a cavity or a disadvantage that a fiber component should be changed and implementing a simple design of the entire fiber laser cavity since only a saturable absorber part, which is a portion of a fiber laser cavity, should be designed, as a carbon nanotube saturable absorber part in a passively mode-locked fiber laser generating apparatus using the saturable absorber. | 07-18-2013 |
20130183275 | Novel Use of Cryptotanshinone - Provided are a composition for stimulating differentiation of MSCs into osteoblasts, which includes cryptotanshinone, and an osteogenesis stimulator including cryptotanshinone and MSCs. | 07-18-2013 |
20130197885 | METHOD FOR PREDICTING DEGREE OF CONTAMINATION OF MOLTEN STEEL DURING LADLE EXCHANGE - The present invention relates to a method for predicting the degree of contamination of molten steel during ladle exchange. The method comprises: setting a casting quantity (Q) and a residual quantity of residual molten steel (Qrm); calculating, based upon the Qrm with proportional coefficients, a casting amount (Qplug) and a casting amount (Qpeak); determining preliminary degrees of contamination; and selecting the smaller of the preliminary degrees to obtain degrees of contamination. | 08-01-2013 |
20130287051 | APPARATUS AND METHOD FOR STABILIZING PULSE OF FIBER-TYPE FEMTOSECOND LASER - Provided are an apparatus and method for stabilizing a pulse of a fiber-type femtosecond laser, and more particularly, to an apparatus for stabilizing a pulse of a fiber-type femtosecond laser, which adjusts a distance between a saturable absorption material and an optical fiber connection unit of the femtosecond laser to automatically perform mode-locking, thereby obtaining a laser pulse stabilized for a long time, and a method for stabilizing the pulse of the fiber-type femtosecond laser. The apparatus for stabilizing a pulse of a fiber-type femtosecond laser in a fiber-type femtosecond laser system including a pump laser ( | 10-31-2013 |
20140134138 | Novel Use of Cryptotanshinone - Provided are a composition for stimulating differentiation of MSCs into osteoblasts, which includes cryptotanshinone, and an osteogenesis stimulator including cryptotanshinone and MSCs. When the cryptotanshinone is treated to the MSCs, the differentiation into osteoblasts is stimulated, and thus osteogenesis of a patient may be stimulated by directly transplanting the differentiation-induced MSCs to the patient. Accordingly, the composition or osteogenesis stimulator may be used to treat patients having disability requiring stimulation of osteogenesis such as osteoporosis, bone fracture, bone grafting including alveolar bone grafting for implant placement, or other bone defects. | 05-15-2014 |